Bafna Pharmaceuticals has informed that Jitendra Kumar Pal ceases to be Company Secretary (CS) & Compliance officer (CO) of the Company with effect from closing of business hours of 21st March 2022. Appointment of Roopa Ravi Kumar as Company Secretary & Compliance officer of the Company with effect from 22nd March 2022 pursuant to section 203 of the Companies Act 2013 and Regulation 6(1) of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015.
The above information is a part of company’s filings submitted to BSE.
